Bio Techne Corp (TECH)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Bio Techne Corp (TECH) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011533
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:63
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Bio Techne Corp (Bio Techne), develops manufactures and sells biotechnology products and instruments for research and clinical diagnostics. The company provides proteins and antibodies, and related immunoassays and other reagents for research under brands such as R&D Systems, Novus, Biologicals and Tocris Bioscience.. It also develops and manufactures biotechnological products such as purified proteins, assays, enzymes, diagnostic kits and antibodies, among others. Bio Techne’s products find application in scientific investigations into biological processes and to find out the nature and progress of particular diseases. The company markets its products through its distribution centers across the world. It provides its products to research and clinical diagnostic communities. Bio Techne is headquartered in Minneapolis, Minnesota, the US.

Bio Techne Corp (TECH) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Bio Techne Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Bio Techne Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Bio Techne Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Bio Techne Corp, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Bio Techne Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Bio Techne Corp, Medical Equipment, Deal Details 12
Venture Financing 12
Advanced Cell Diagnostics Raises USD22 Million in Series C Financing 12
Advanced Cell Diagnostics Raises US$12 Million In Series B Financing 14
Cell Biosciences Secures US$13 Million In Second Tranche Of Series F Financing 15
Partnerships 16
Bio-Techne Enters into Agreement with B-MoGen Biotechnologies 16
Leica Biosystems Enters into Agreement with Advanced Cell Diagnostics 17
Luminex Enters into Distribution Agreement with Bio-Techne 18
Indica Labs Enters into Co-Marketing Agreement with Advanced Cell Diagnostics 19
MicroMatrices Associates Enters into Co-Development Agreement with Advanced Cell Diagnostics 20
Leica Biosystems Enters into Co-Marketing Agreement with Advanced Cell Diagnostics 21
Life Technologies Enters Into Distribution Agreement With Advanced Cell Diagnostics 22
Advanced Cell Diagnostics Enters Into Co-Development Agreement With Definiens 23
Equity Offering 24
Astute Medical Raises USD43 Million in Private Palcement of Shares 24
ProteinSimple Withdraws IPO 25
Acquisition 26
Bio Techne Acquires Trevigen 26
Bio-Techne Acquires Advanced Cell Diagnostics 27
Bio-Techne Acquires Space Import-Export for USD9 Million 29
Bio-Techne Acquires Cliniqa 30
Bio-Techne Acquires Cyvek 31
Bio-Techne Completes Acquisition of ProteinSimple for USD308 Million 32
Techne Completes Acquisition Of Bionostics For US$104 Million 34
Cell Biosciences Acquires Brightwell Technologies 36
Techne Acquires Boston Biochem And Boston Biochem 37
Bio Techne Corp – Key Competitors 38
Bio Techne Corp – Key Employees 39
Bio Techne Corp – Locations And Subsidiaries 40
Head Office 40
Other Locations & Subsidiaries 40
Recent Developments 42
Financial Announcements 42
Oct 31, 2017: Bio-Techne Releases First Quarter Fiscal 2018 Results 42
Aug 08, 2017: Bio-Techne Releases Fourth Quarter Fiscal 2017 Results 44
May 02, 2017: Bio-Techne Releases Third Quarter Fiscal 2017 Results 47
Feb 07, 2017: Bio-Techne Releases Second Quarter Fiscal 2017 Results 49
Oct 31, 2016: Bio-Techne Releases First Quarter Fiscal 2017 Results 51
Aug 17, 2016: Bio-Techne Releases Fourth Quarter Fiscal 2016 Results 53
May 03, 2016: Bio-Techne Releases Third Quarter Fiscal 2016 Results 56
Feb 02, 2016: Bio-Techne Releases Second Quarter Fiscal 2016 Results 58
Corporate Communications 60
Oct 26, 2017: Bio-Techne Adds Two New Directors to Its Board 60
Product News 61
Nov 20, 2017: Bio-Techne Offers Updated Novus Panel Builder, Facilitating Multicolor Flow Cytometry Panel Design 61
Other Significant Developments 62
Jan 09, 2017: COPD Biomarker Qualification Consortium Partners with Bio-Techne to Identify COPD Indicator 62
Appendix 63
Methodology 63
About GlobalData 63
Contact Us 63
Disclaimer 63

List of Tables
Bio Techne Corp, Medical Equipment, Key Facts, 2017 2
Bio Techne Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Bio Techne Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Bio Techne Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Bio Techne Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Bio Techne Corp, Deals By Market, 2011 to YTD 2017 9
Bio Techne Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Advanced Cell Diagnostics Raises USD22 Million in Series C Financing 12
Advanced Cell Diagnostics Raises US$12 Million In Series B Financing 14
Cell Biosciences Secures US$13 Million In Second Tranche Of Series F Financing 15
Bio-Techne Enters into Agreement with B-MoGen Biotechnologies 16
Leica Biosystems Enters into Agreement with Advanced Cell Diagnostics 17
Luminex Enters into Distribution Agreement with Bio-Techne 18
Indica Labs Enters into Co-Marketing Agreement with Advanced Cell Diagnostics 19
MicroMatrices Associates Enters into Co-Development Agreement with Advanced Cell Diagnostics 20
Leica Biosystems Enters into Co-Marketing Agreement with Advanced Cell Diagnostics 21
Life Technologies Enters Into Distribution Agreement With Advanced Cell Diagnostics 22
Advanced Cell Diagnostics Enters Into Co-Development Agreement With Definiens 23
Astute Medical Raises USD43 Million in Private Palcement of Shares 24
ProteinSimple Withdraws IPO 25
Bio Techne Acquires Trevigen 26
Bio-Techne Acquires Advanced Cell Diagnostics 27
Bio-Techne Acquires Space Import-Export for USD9 Million 29
Bio-Techne Acquires Cliniqa 30
Bio-Techne Acquires Cyvek 31
Bio-Techne Completes Acquisition of ProteinSimple for USD308 Million 32
Techne Completes Acquisition Of Bionostics For US$104 Million 34
Cell Biosciences Acquires Brightwell Technologies 36
Techne Acquires Boston Biochem And Boston Biochem 37
Bio Techne Corp, Key Competitors 38
Bio Techne Corp, Key Employees 39
Bio Techne Corp, Subsidiaries 40

★海外企業調査レポート[Bio Techne Corp (TECH)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Clarivate Plc (CLVT):企業の財務・戦略的SWOT分析
    Clarivate Plc (CLVT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Bioanalytical Systems, Inc.:企業の戦略・SWOT・財務情報
    Bioanalytical Systems, Inc. - Strategy, SWOT and Corporate Finance Report Summary Bioanalytical Systems, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Mitsubishi Motors Corporation (7211):企業の財務・戦略的SWOT分析
    Mitsubishi Motors Corporation (7211) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Dedeman Hotels & Resorts International:企業の戦略・SWOT・財務分析
    Dedeman Hotels & Resorts International - Strategy, SWOT and Corporate Finance Report Summary Dedeman Hotels & Resorts International - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • GraIncorp Ltd (GNC):企業の財務・戦略的SWOT分析
    Summary GraIncorp Ltd (GrainCorp) is a grain supply company that provides storage services. The company offers services such as storage, marketing, handling, and logistics services to the grain growing industry. It also provides services such as research and development and commercialization; seed b …
  • ifa systems AG (IS8):企業の財務・戦略的SWOT分析
    ifa systems AG (IS8) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • 3M Company:企業のM&A・事業提携・投資動向
    3M Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's 3M Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • Aerie Pharmaceuticals Inc (AERI):製薬・医療:M&Aディール及び事業提携情報
    Summary Aerie Pharmaceuticals Inc (Aerie) is a pharmaceutical company that discovers, develops and commercializes therapies for the treatment of patients with glaucoma and other diseases of the eye. The company’s product candidates comprise rhopressa, a once-daily eye drop which is used for the redu …
  • Merrimack Pharmaceuticals Inc (MACK):医療機器:M&Aディール及び事業提携情報
    Summary Merrimack Pharmaceuticals Inc (Merrimack) is a clinical stage biopharmaceutical company that develops and commercializes medicines for the treatment of various types of cancers. The company’s marketed portfolio consists of Onivyde (irinotecan liposome injection) that encases irinotecan (mark …
  • Majestic Wine plc (WINE):企業の財務・戦略的SWOT分析
    Majestic Wine plc (WINE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Bonheur ASA (BON):企業の財務・戦略的SWOT分析
    Summary Bonheur ASA (Bonheur) is an oil and gas investment service provider that offers investment services for various energy sectors. The company invests in renewable energy, cruise, shipping and offshore wind, offshore drilling, and other investments. It operates shipping vessels for transport an …
  • ManTech International Corporation:企業の戦略・SWOT・財務情報
    ManTech International Corporation - Strategy, SWOT and Corporate Finance Report Summary ManTech International Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Vietnam National Oil and Gas Group-エネルギー分野:企業M&A・提携分析
    Summary Vietnam National Oil and Gas Group (Petrovietnam) is an oil and gas organization that offers oil and gas exploration and development services. The organization's services include oil and natural gas exploration and production, petroleum and financial services, processing of petrochemicals, r …
  • Driver Group Plc (DRV):企業の財務・戦略的SWOT分析
    Driver Group Plc (DRV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • European Investment Bank:企業の戦略的SWOT分析
    European Investment Bank - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Insys Therapeutics Inc (INSY)-製薬・医療分野:企業M&A・提携分析
    Summary Insys Therapeutics Inc (Insys) is a specialty pharmaceutical company, which discovers, develops and commercializes novel drug delivery systems. The company’s flagship product, Subsys is a sublingual fentanyl spray for breakthrough cancer pain (BTCP) in opioid-tolerant patients. Its lead prod …
  • Idexx Laboratories Inc (IDXX):企業の財務・戦略的SWOT分析
    Idexx Laboratories Inc (IDXX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Alexander Forbes Group Holdings Ltd (AFH):企業の財務・戦略的SWOT分析
    Alexander Forbes Group Holdings Ltd (AFH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Clinical Trial Consultants AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Clinical Trial Consultants AB (CTC AB) is a contract research organization that conducts hospital-based early phase clinical trials. The organization offers services which include pharmacovigilance, human PET imaging studies, medical and scientific advisory, quality assurance and outsourcing …
  • Airborne Tactical Advantage Company:企業の戦略・SWOT・財務情報
    Airborne Tactical Advantage Company - Strategy, SWOT and Corporate Finance Report Summary Airborne Tactical Advantage Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆